Thus, an altered AQP5 expression due to the AQP5 -1364A/C promoter SNP could impact on the development, duration and recovery of an AKI potentially explaining the higher mortality of AA genotypes associated with an increased AQP5 expression [14]. This evidence concerns the gene AQP5 and acute kidney injury.